Position Statement on Postprandial Hyperinsulinemic Hypoglycemia after Bariatric Surgery

Published March 2017

Prepared by Dan Eisenberg, M.D., M.S., Dan E. Azagury, M.D., Saber Ghiassi, M.D., Brandon T. Grover, D.O., Julie J. Kim, M.D.

The following position statement is issued by the American Society for Metabolic and Bariatric Surgery (ASMBS) for the purpose of enhancing quality of care in metabolic and bariatric surgery. In this statement, suggestions for management are presented that are derived from available knowledge, peer-reviewed scientific literature, and expert opinion. This was accomplished by performing…

Read More

Position Statement on Single-Anastomosis Duodenal Switch

Published May 2016

Prepared by Julie Kim, M.D., F.A.C.S., F.A.S.M.B.S.,* on behalf of the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee

Preamble

The following statement is issued by the American Society for Metabolic and Bariatric Surgery (ASMBS) in response to numerous inquiries made to the Society by patients, physicians, society members, hospitals, and others regarding single-anastomosis duodenal switch as a primary treatment for obesity or metabolic disease. This recommendation is based on current clinical knowledge,…

Read More

Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA)

Published May 2016

Download Part 1 Download Executive Summary

NOTE: Part 1 is originally published with the lipid association.

Prepared by Harold Bays, M.D., F.T.O.S., F.A.C.C., F.A.C.E., F.N.L.A., Shanu N. Kothari, M.D., F.A.C.S., F.A.S.M.B.S., Dan E. Azagury, M.D., Ninh T. Nguyen, M.D., F.A.C.S., F.A.S.M.B.S., Terry A. Jacobson, M.D., F.A.C.P., F.N.L.A., Carl Orringer, M,D., Deborah B. Horn, D.O., M.P.H., Diplomate A.B.O.M., John M. Morton, M.D., M.P.H., F.A.C.S., F.A.S.M.B.S., Eric C. Westman, M.D., M.H.S., Diplomate A.B.O.M., Peter…

Read More

Preoperative Supervised Weight Loss Requirements

Published April 2016

In 2011, the American Society for Metabolic and Bariatric Surgery (ASMBS) published a position statement on preoperative weight loss requirements [1]. This statement was developed in response to inquiries made to the ASMBS by patients, physicians, hospitals, health insurance payers, the media, and others regarding the need for and efficacy of insurance mandated preoperative weight loss requirements before undergoing bariatric surgery. In the evolving field of bariatric surgery, it is periodically necessary to provide updated position statements…

Read More

Alcohol Use Before and After Bariatric Surgery

Published February 2016

Prepared by Manish Parikh, M.D., Jason M. Johnson, Naveen Ballem, M.D.

The following position statement is issued by the American Society for Metabolic and Bariatric Surgery (ASMBS) for the purpose of enhancing quality of care in bariatric surgery. In this statement, suggestions for management are presented that are derived from available knowledge, peer-reviewed scientific literature, and expert opinion. This was accomplished by performing a systematic review of currently available literature regarding alcohol consumption (both pre-…

Read More

Position Statement on Intragastric Balloon Therapy Endorsed by SAGES

Published December 2015

Prepared by Mohamed R. Ali, M.D., *, Fady Moustarah, M.D., Julie J. Kim, M.D., on behalf of the American Society for Metabolic and Bariatric Surgery Clinical Issues Committee

The American Society for Metabolic and Bariatric Surgery (ASMBS) has issued the following position statement in response to numerous inquiries made to the Society by patients, physicians, society members, hospitals, health insurance payors, the media, and others regarding the role of intragastric balloons in the treatment of…

Read More

Vagal Blocking Therapy for Obesity

Published December 2015

The vagus nerve plays a significant role in the regulation of stomach functions, secretion of ghrelin, pancreatic endocrine and exocrine secretion, and glycemic control. VBLOC, a new therapy for obesity, induces intermittent intra-abdominal vagal blocking with the use of high-frequency electrical energy.

Read More

Prevention and Detection of Gastrointestinal Leak

Published May 2015

Gastrointestinal (GI) leak is a known complication after both gastric bypass (GB) and sleeve gastrectomy (SG) with a reported incidence, in large published case series of open and laparoscopic cases, between .1% and 8.3% after GB and 0% and 7% after SG.

Read More

Metabolic bone changes after bariatric surgery

Published March 2014

Despite the undisputed health benefits, bariatric surgery requires not only an extensive preoperative evaluation but also a commitment from the patient to participate in life-long follow-up. Long-term follow-up after bariatric surgery focuses on weight loss maintenance and adherence to aftercare recommendations regarding micronutrient supplementation.

Read More

Systematic Review on Reoperative Surgery

Published February 2014

Morbid obesity is a chronic disease that requires lifetime treatment. While bariatric surgery is highly effective and durable therapy, as with many other chronic diseases requiring medical or surgical therapy, there will be patients who respond well to an initial therapy and others with only a partial response.

Read More